Type 2 diabetes: Added benefit of canagliflozin plus metformin is not proven

21 noviembre 2014

As in the first dossier assessment of canagliflozin, the drug manufacturer provided no suitable data for the fixed combination with metformin either. Therefore, no added benefit of canagliflozin plus metformin has been demonstrated for type 2 diabetes care.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/Ohz-JET86J4/141121102823.htm

Volver